INTS vs LW · $7.7M cap vs P/E 21, rev $6.45B
Intensity Therapeutics, Inc. Common stock (INTS) versus Lamb Weston Holdings Inc (LW) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Lamb Weston Holdings Inc (LW) is a packaged foods company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported LW revenue for 2025-05-25 was $6.45B. Net income was $357.2M. Revenue was down 0.3% from 2024-05-26 to 2025-05-25. LW currently screens at market cap $7.40B and trailing P/E 20.6.
INTS currently screens at market cap $7.7M. LW currently screens at market cap $7.40B and trailing P/E 20.6.
Not investment advice. Open the INTS and LW stock pages for the full models.
Not investment advice.